Prevalence of covid-19 breakthrough after vaccination and adverse effects of vaccines

Fatima Ehsan; Fouzia Hanif; Qudsia Ishaq; Maleha Asim; Maria Yousaf; Aqeel Mansoor

2024, Vol: 49, Issue: 2

49 / 2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Author_ Certificate.docx
Bank Reciept

« Previous Article

Original Research

RMJ. 2024; 49(2): 270-273

Prevalence of covid-19 breakthrough after vaccination and adverse effects of vaccines

Fatima Ehsan, Fouzia Hanif, Qudsia Ishaq, Maleha Asim, Maria Yousaf, Aqeel Mansoor.

Abstract
Objective: To assess the prevalence of breakthrough Covid 19 after vaccination and adverse effects of vaccines.
Methodology: A descriptive cross-sectional study was conducted at three mega vaccination centers in Islamabad from December 1, 2021, to May 1, 2022. The sample size consisted of 300 participants (both males and females) in the age range of 30-60 years. To avoid ambiguities in answers, we included only those participants who were fully vaccinated. Among these, 150 were healthy individuals and 150 with co-morbidities, were selected through convenience sampling. Data were collected and analyzed using a pre-designed questionnaire and SPSS version 21.
Results: A significant association between breakthrough COVID-19 and age and symptoms were found in fully vaccinated individuals with and without comorbidities. The type of vaccine had a significant association only in individuals without medical illness. No significant side effects of the vaccine or gender association were found in either group. We also found a significant association between breakthrough COVID-19 symptoms and the type of vaccine used.
Conclusion: A significant association between vaccine type and breakthrough COVID was observed only in healthy individuals, probably because of their different mechanisms of action.

Key words: Vaccines, Pakistan, Comorbidities, Covid 19.

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Fatima Ehsan Articles by Fouzia Hanif Articles by Qudsia Ishaq Articles by Maleha Asim Articles by Maria Yousaf Articles by Aqeel Mansoor
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Ehsan F, Hanif F, Ishaq Q, Asim M, Yousaf M, Mansoor A. Prevalence of covid-19 breakthrough after vaccination and adverse effects of vaccines. RMJ. 2024; 49(2): 270-273.

Web Style

Ehsan F, Hanif F, Ishaq Q, Asim M, Yousaf M, Mansoor A. Prevalence of covid-19 breakthrough after vaccination and adverse effects of vaccines. https://www.rmj.org.pk/?mno=171108 [Access: April 25, 2024].

AMA (American Medical Association) Style

Ehsan F, Hanif F, Ishaq Q, Asim M, Yousaf M, Mansoor A. Prevalence of covid-19 breakthrough after vaccination and adverse effects of vaccines. RMJ. 2024; 49(2): 270-273.

Vancouver/ICMJE Style

Ehsan F, Hanif F, Ishaq Q, Asim M, Yousaf M, Mansoor A. Prevalence of covid-19 breakthrough after vaccination and adverse effects of vaccines. RMJ. (2024), [cited April 25, 2024]; 49(2): 270-273.

Harvard Style

Ehsan, F., Hanif, . F., Ishaq, . Q., Asim, . M., Yousaf, . M. & Mansoor, . A. (2024) Prevalence of covid-19 breakthrough after vaccination and adverse effects of vaccines. RMJ, 49 (2), 270-273.

Turabian Style

Ehsan, Fatima, Fouzia Hanif, Qudsia Ishaq, Maleha Asim, Maria Yousaf, and Aqeel Mansoor. 2024. Prevalence of covid-19 breakthrough after vaccination and adverse effects of vaccines. Rawal Medical Journal, 49 (2), 270-273.

Chicago Style

Ehsan, Fatima, Fouzia Hanif, Qudsia Ishaq, Maleha Asim, Maria Yousaf, and Aqeel Mansoor. "Prevalence of covid-19 breakthrough after vaccination and adverse effects of vaccines." Rawal Medical Journal 49 (2024), 270-273.

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Ehsan, F., Hanif, . F., Ishaq, . Q., Asim, . M., Yousaf, . M. & Mansoor, . A. (2024) Prevalence of covid-19 breakthrough after vaccination and adverse effects of vaccines. Rawal Medical Journal, 49 (2), 270-273.

Author Login Reviewer Login Editorial Policies Conflict of Interest Policy Plagiarism Policy Advertising Policy

About Rawal Medical Journal

Contact Information

How to cite this article


About Rawal Medical Journal Publication, subscription and Editorial office PMA House G/220-B Liaquat Road, Rawalpindi. Phone: 051-555-9812, Fax: 051-553-7088 Email: drnkhokhar@ya ... Read more. For best results, please use Internet Explorer or Google Chrome.	Contact Information